Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinuvel Pharmaceuticals Ltd
OTC:CLVLY
|
AU |
Wall St Price Targets
CLVLY Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for CLVLY is 17.63 USD with a low forecast of 9.43 USD and a high forecast of 29.57 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLVLY's stock price target?
Price Target
17.63
USD
According to Wall Street analysts, the average 1-year price target for CLVLY is 17.63 USD with a low forecast of 9.43 USD and a high forecast of 29.57 USD.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
